Rgt Wealth Advisors, LLC Savara Inc Transaction History

Rgt Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$1.05 - $1.36 $7,875 - $10,200	-7,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.04 - $1.34 $7,800 - $10,050	7,500 New	7,500 $9,000
Q2 2021 Aug 13, 2021	SELL	$1.51 - $2.29 $15,100 - $22,900	-10,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.8 - $3.05 $18,000 - $30,500	10,000 New	10,000 $25,000

122

121M

123K

14.7K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $494M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Rgt Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Rgt Wealth Advisors, LLC with notifications on news.